Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
13.40
-0.15 (-1.11%)
Jan 29, 2026, 3:16 PM EST - Market open
Pulse Biosciences Employees
Pulse Biosciences had 75 employees as of December 31, 2024. The number of employees increased by 19 or 33.93% compared to the previous year.
Employees
75
Change (1Y)
19
Growth (1Y)
33.93%
Revenue / Employee
$1,147
Profits / Employee
-$996,440
Market Cap
908.09M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 75 | 19 | 33.93% |
| Dec 31, 2023 | 56 | -5 | -8.20% |
| Dec 31, 2022 | 61 | -81 | -57.04% |
| Dec 31, 2021 | 142 | 47 | 49.47% |
| Dec 31, 2020 | 95 | 13 | 15.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| DENTSPLY SIRONA | 14,000 |
| Azenta | 3,000 |
| Embecta | 1,850 |
| AtriCure | 1,300 |
| STAAR Surgical Company | 1,157 |
| AngioDynamics | 675 |
| LeMaitre Vascular | 664 |
| Kestra Medical Technologies | 330 |
PLSE News
- 14 days ago - Pulse Biosciences, Inc. (PLSE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 20 days ago - Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - Business Wire
- 23 days ago - Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium - Business Wire
- 4 weeks ago - Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 5 weeks ago - Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation - Business Wire
- 7 weeks ago - Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology - Business Wire
- 2 months ago - Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences - Business Wire